Advisor Partners II’s Bristol-Myers Squibb BMY Stock Holding History

Advisor Partners II’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	$4.4M	Sell	75,803 -8,090	-10%	-$496K	0.18%	110
2023 Q2	$5.36M	Buy	83,893 +1,768	+2%	+$119K	0.25%	71
2023 Q1	$5.69M	Sell	82,125 -2,837	-3%	-$200K	0.31%	60
2022 Q4	$6.11M	Buy	84,962 +7,720	+10%	+$582K	0.38%	48
2022 Q3	$5.49M	Buy	+77,242	New	+$5.6M	0.42%	41

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Advisor Partners II's BMY Position: Q3 2023 in Review

Advisor Partners II reduced its Bristol-Myers Squibb (BMY) stake by 9.6% in Q3 2023, selling an estimated $496K and leaving 75,803 shares worth $4.4M. The position accounts for 0.18% of the portfolio, ranked #110.

Advisor Partners II first reported a position in BMY in Q3 2022 and has held it in 5 quarters since. The position peaked at $6.11M in Q4 2022. 2,387 funds tracked by Wall St. Rank hold BMY as of Q3 2023.

Advisor Partners II held 75,803 shares of Bristol-Myers Squibb worth $4.4M as of Q3 2023.
Advisor Partners II sold 8,090 Bristol-Myers Squibb shares in Q3 2023, an estimated $496K.
Bristol-Myers Squibb made up 0.18% of Advisor Partners II's portfolio in Q3 2023, its #110 holding.
Advisor Partners II first reported a position in Bristol-Myers Squibb in Q3 2022 and has held it in 5 quarters since.
Advisor Partners II's Bristol-Myers Squibb position peaked at $6.11M in Q4 2022.
2,387 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2023.

Based on Advisor Partners II's 13F filing for Q3 2023, filed 26 Oct 2023.